Reaction Details |
| Report a problem with these data |
Target | cGMP-dependent 3',5'-cyclic phosphodiesterase [574-941] |
---|
Ligand | BDBM14774 |
---|
Substrate/Competitor | BDBM10851 |
---|
Meas. Tech. | Phosphodiesterase (PDE) Inhibition Assay |
---|
IC50 | >200000±n/a nM |
---|
Citation | Card, GL; England, BP; Suzuki, Y; Fong, D; Powell, B; Lee, B; Luu, C; Tabrizizad, M; Gillette, S; Ibrahim, PN; Artis, DR; Bollag, G; Milburn, MV; Kim, SH; Schlessinger, J; Zhang, KY Structural basis for the activity of drugs that inhibit phosphodiesterases. Structure12:2233-47 (2004) [PubMed] Article |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
cGMP-dependent 3',5'-cyclic phosphodiesterase [574-941] |
---|
Name: | cGMP-dependent 3',5'-cyclic phosphodiesterase [574-941] |
Synonyms: | CGS-PDE | Cyclic GMP-stimulated phosphodiesterase | PDE2A | PDE2A_HUMAN | Phosphodiesterase Type 2 (PDE2A) | cGMP-dependent 3,5-cyclic phosphodiesterase | cGSPDE |
Type: | Enzyme |
Mol. Mass.: | 42724.46 |
Organism: | Homo sapiens (Human) |
Description: | Recombinant catalytic domain (H574-E941) of human PDE2A. |
Residue: | 368 |
Sequence: | HMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYK
IDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISC
MCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKD
YQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQT
KGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKL
LQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPIN
GCCSLDAE
|
|
|
BDBM14774 |
---|
BDBM10851 |
---|
Name | BDBM14774 |
Synonyms: | 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide | CHEMBL193240 | DAXAS | ROF | Roflumilast |
Type | Small organic molecule |
Emp. Form. | C17H14Cl2F2N2O3 |
Mol. Mass. | 403.207 |
SMILES | FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl |
Structure |
|